These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4740202)

  • 1. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the muscular effects of adenosine by lidoflazine and dipyridamole in isolated atria.
    Küçükhüseyin C; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):243-50. PubMed ID: 4851866
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues.
    Van Nueten JM; Janssen PA
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):37-55. PubMed ID: 4746630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute effect of lidoflazine on the electrocardiographic agitation discharge in atrial frequency stimulation (studies on patients with stress-induced coronary insufficiency)].
    Lehmann HU; Beck OA; Hochrein H
    Z Kardiol; 1975 May; 64(5):396-410. PubMed ID: 1189535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrocardiographic studies on the drug Clinium].
    Széplaki S; Böszörményi E; Werkner J; Szmandra J
    Orv Hetil; 1974 Jan; 115(1):25-8. PubMed ID: 4809138
    [No Abstract]   [Full Text] [Related]  

  • 9. Resting, exercise and postexercise heart rate and systolic time intervals in normal men treated with lidoflazine.
    De Cock W; Schuermans V; Jageneau A; De Crée J; Brugmans J
    Arzneimittelforschung; 1973 Oct; 23(10):1450-4. PubMed ID: 4591313
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lidoflazine derivatives with cycloaliphatic residues of coronary dilator activity].
    Carissimi M; Gentili P; Picciòla G; Ravenna F
    Farmaco Sci; 1977 Jun; 32(6):461-70. PubMed ID: 872926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic effects of trimetazidine to adrenaline.
    Matsubara I; Nakagawa Y; Imai S
    Jpn J Pharmacol; 1974 Apr; 24(2):325-6. PubMed ID: 4546727
    [No Abstract]   [Full Text] [Related]  

  • 12. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 13. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
    Schaper WK; Xhoneux R; Jageneau AH; Janssen PA
    J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial reactive hyperemia responses in the dog after aminophylline and lidoflazine.
    Bittar N; Pauly TJ
    Am J Physiol; 1971 Mar; 220(3):812-5. PubMed ID: 4322835
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
    Jageneau AH; Schaper WK; Van Gerven W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of lidoflazine on the exercise capacity of normal volunteers: double-blind cycloergometric evaluations.
    Jageneau A; Brugmans J
    Arzneimittelforschung; 1972 Feb; 22(2):457-9. PubMed ID: 4554634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lidoflazine (R 7904) on uptake and release of serotonin by human platelets in vitro.
    De Clerck FF; Reneman RS
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(3):261-9. PubMed ID: 4270070
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.